Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - AVENUE THERAPEUTICS, INC. | tv486678_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - AVENUE THERAPEUTICS, INC. | tv486678_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - AVENUE THERAPEUTICS, INC. | tv486678_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - AVENUE THERAPEUTICS, INC. | tv486678_ex31-1.htm |
| EX-10.9 - EXHIBIT 10.9 - AVENUE THERAPEUTICS, INC. | tv486678_ex10-9.htm |
| EX-10.7 - EXHIBIT 10.7 - AVENUE THERAPEUTICS, INC. | tv486678_ex10-7.htm |
| 10-K - FORM 10-K - AVENUE THERAPEUTICS, INC. | tv486678_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Avenue Therapeutics, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-219972) of Avenue Therapeutics, Inc. of our report dated March 1, 2018 relating to the financial statements which appear in this Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 1, 2018